Policy & Compounding
Peptides Have Arrived: HHS Won't Pursue Pharmacies Making Six of Them
HHS filed a draft policy saying it won't pursue pharmacies compounding six peptides. What changed, what didn't, and how to stay safe.
Policy & Compounding
FDA decisions, state bills and shortages, and the compounding pharmacies in the middle of them.
Policy & Compounding
No B12, No Niacinamide: How to Check What's in Your GLP-1 Compound Before It Ships
Want no B12 or niacinamide in your GLP-1 compound? What your vial label should list, what to ask the pharmacy, and how to check additives first.
Policy & Compounding
The FDA Sent a Peptide Compounding Plan for Review: What Changes, and What Hasn't Yet
The White House logged an FDA peptide compounding policy on Oct 14. See what it could change, what's still not legal, and what to watch.
Policy & Compounding
Peptides Are Coming to Telehealth Checkouts. Here Is What to Look For.
Big telehealth brands plan to sell peptides. Learn which ones have a legal path, what the LegitScript seal checks, and the red flags.
Policy & Compounding
FDA Sent a Compounding Pharmacy a Warning Letter. Here's What It Says.
FDA's September 2026 warning letter has two separate sets of findings. See which one affects patients and which is a legal dispute.
Policy & Compounding
Lifestyle Habits Stacked Against Peptides: Which Makes You Live Longer
Most peptides in a wellness stack have zero human trials. See what the research shows, and the 12-year gap five basic habits produced.
More in Policy & Compounding
- Policy & Compounding
1 in 18 Black Market Peptide Vials Matched Its Label
An Australian lab tested 18 vials sold as retatrutide. One matched its label. See what the dosing errors were and why a purity test proves little.
- Policy & Compounding
People Are Injecting 'Barbie Peptides' to Tan. Here's What the FDA Actually Says About Melanotan
Melanotan II is sold as a tanning shortcut. See the FDA's own safety language, the published case reports, and where the 2026 peptide review stands.
- Policy & Compounding
Why Isn't My Pharmacy Licensed in My State? What to Check
Your vial says one company but your provider lists another pharmacy. See why, what an outsourcing facility is, and how to check your state license.
- Policy & Compounding
FDA Panel Backs 6 Peptides for Compounding: What's Next
An FDA panel backed 6 of 7 peptides for the compounding list. See the votes, what each was proposed to treat, and what has to happen next.
- Policy & Compounding
The FDA Peptide Panel: Could These 7 Be Compounded?
An FDA panel meets July 23-24 to weigh whether 7 peptides can be compounded. See which peptides, what the FDA recommends, and what it means.
- Cost & Coverage
Who's Using GLP-1s Now? The 2026 Numbers, Explained
GLP-1 use hit a new high in 2026: about 11% of US adults now take one. See who is using them, the brand vs compounded split, and what it means.
